ロシグリタゾンの世界市場レポート2020

• 英文タイトル：Global Rosiglitazone (CAS 122320-73-4) Sales Market Report 2020

• レポートコード：QY20ST-06959 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥560,000 (USD4,000)	▷ お問い合わせ
Multi User	￥840,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,120,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、世界のロシグリタゾン市場について種類別（ロシグリタゾン錠、マレイン酸ロシグリタゾン錠、塩酸ロシグリタゾン錠、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ロシグリタゾン市場の概要 ・世界の主要地域別ロシグリタゾン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のロシグリタゾン市場規模2015-2026：種類別（ロシグリタゾン錠、マレイン酸ロシグリタゾン錠、塩酸ロシグリタゾン錠、その他） ・世界のロシグリタゾン市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局） ・ロシグリタゾンの北米市場規模2015-2020 ・ロシグリタゾンのヨーロッパ市場規模2015-2020 ・ロシグリタゾンの中国市場規模2015-2020 ・ロシグリタゾンの日本市場規模2015-2020 ・ロシグリタゾンの東南アジア市場規模2015-2020 ・ロシグリタゾンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ロシグリタゾンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ロシグリタゾンの市場動向・機会・課題 ・調査の結論

A recently published report by QY Research titled Global Rosiglitazone (CAS 122320-73-4) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Rosiglitazone (CAS 122320-73-4) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Rosiglitazone (CAS 122320-73-4), C18H19N3O3S, the formula weight is 357.43, and its form is powder.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Rosiglitazone (CAS 122320-73-4) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Rosiglitazone (CAS 122320-73-4) industry.
Based on our recent survey, we have several different scenarios about the Rosiglitazone (CAS 122320-73-4) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Rosiglitazone (CAS 122320-73-4) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Rosiglitazone (CAS 122320-73-4) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Rosiglitazone (CAS 122320-73-4) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Rosiglitazone (CAS 122320-73-4) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Rosiglitazone (CAS 122320-73-4) market. The report also includes nautical information, where it shows Rosiglitazone (CAS 122320-73-4) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Rosiglitazone (CAS 122320-73-4) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Rosiglitazone (CAS 122320-73-4) market.
Rosiglitazone is more effective in controlling blood sugar and is suitable for the treatment of non-insulin-dependent (type II) diabetes.
Geographical Analysis:
Based on region, the global Rosiglitazone (CAS 122320-73-4) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Rosiglitazone (CAS 122320-73-4) market are
Hengrui Pharma
GSK
Taiji Group
Shengjitang Pharma
Huanghe Pharma
Wanma Pharma
Jingxin Pharma
STADA
Segment by Type
Rosiglitazone Tablets
Rosiglitazone Maleate Tablets
Rosiglitazone Hydrochloride Tablets
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Rosiglitazone (CAS 122320-73-4) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Rosiglitazone (CAS 122320-73-4) market.
• The market share of the global Rosiglitazone (CAS 122320-73-4) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Rosiglitazone (CAS 122320-73-4) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Rosiglitazone (CAS 122320-73-4) market.

レポート目次

---

1 Rosiglitazone (CAS 122320-73-4) Market Overview
1.1 Rosiglitazone (CAS 122320-73-4) Product Scope
1.2 Rosiglitazone (CAS 122320-73-4) Segment by Type
1.2.1 Global Rosiglitazone (CAS 122320-73-4) Sales by Type (2020-2026)
1.2.2 Rosiglitazone Tablets
1.2.3 Rosiglitazone Maleate Tablets
1.2.4 Rosiglitazone Hydrochloride Tablets
1.2.5 Others
1.3 Rosiglitazone (CAS 122320-73-4) Segment by Application
1.3.1 Global Rosiglitazone (CAS 122320-73-4) Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Rosiglitazone (CAS 122320-73-4) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Rosiglitazone (CAS 122320-73-4) Sales Growth Rate (2015-2026)
1.4.2 Global Rosiglitazone (CAS 122320-73-4) Revenue and Growth Rate (2015-2026)
1.4.3 Global Rosiglitazone (CAS 122320-73-4) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Rosiglitazone (CAS 122320-73-4) Industry Impact
1.5.1 How the Covid-19 is Affecting the Rosiglitazone (CAS 122320-73-4) Industry
1.5.1.1 Rosiglitazone (CAS 122320-73-4) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Rosiglitazone (CAS 122320-73-4) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Rosiglitazone (CAS 122320-73-4) Players to Combat Covid-19 Impact

2 Rosiglitazone (CAS 122320-73-4) Estimate and Forecast by Region
2.1 Global Rosiglitazone (CAS 122320-73-4) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Rosiglitazone (CAS 122320-73-4) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Region (2015-2020)
2.2.2 Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Region (2015-2020)
2.3 Global Rosiglitazone (CAS 122320-73-4) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Rosiglitazone (CAS 122320-73-4) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Rosiglitazone (CAS 122320-73-4) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Rosiglitazone (CAS 122320-73-4) Estimates and Projections (2015-2026)
2.4.2 Europe Rosiglitazone (CAS 122320-73-4) Estimates and Projections (2015-2026)
2.4.3 China Rosiglitazone (CAS 122320-73-4) Estimates and Projections (2015-2026)
2.4.4 Japan Rosiglitazone (CAS 122320-73-4) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Rosiglitazone (CAS 122320-73-4) Estimates and Projections (2015-2026)
2.4.6 India Rosiglitazone (CAS 122320-73-4) Estimates and Projections (2015-2026)
3 Global Rosiglitazone (CAS 122320-73-4) Competition Landscape by Players
3.1 Global Top Rosiglitazone (CAS 122320-73-4) Players by Sales (2015-2020)
3.2 Global Top Rosiglitazone (CAS 122320-73-4) Players by Revenue (2015-2020)
3.3 Global Rosiglitazone (CAS 122320-73-4) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rosiglitazone (CAS 122320-73-4) as of 2019)
3.4 Global Rosiglitazone (CAS 122320-73-4) Average Price by Company (2015-2020)
3.5 Manufacturers Rosiglitazone (CAS 122320-73-4) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Rosiglitazone (CAS 122320-73-4) Players (Opinion Leaders)
4 Global Rosiglitazone (CAS 122320-73-4) Market Size by Type
4.1 Global Rosiglitazone (CAS 122320-73-4) Historic Market Review by Type (2015-2020)
4.1.1 Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
4.1.2 Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Type (2015-2020)
4.1.3 Global Rosiglitazone (CAS 122320-73-4) Price by Type (2014-2020)
4.2 Global Rosiglitazone (CAS 122320-73-4) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Rosiglitazone (CAS 122320-73-4) Sales Forecast by Type (2021-2026)
4.2.2 Global Rosiglitazone (CAS 122320-73-4) Revenue Forecast by Type (2021-2026)
4.2.3 Global Rosiglitazone (CAS 122320-73-4) Price Forecast by Type (2021-2026)
5 Global Rosiglitazone (CAS 122320-73-4) Market Size by Application
5.1 Global Rosiglitazone (CAS 122320-73-4) Historic Market Review by Application (2015-2020)
5.1.1 Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)
5.1.2 Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Application (2015-2020)
5.1.3 Global Rosiglitazone (CAS 122320-73-4) Price by Application (2015-2020)
5.2 Global Rosiglitazone (CAS 122320-73-4) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Rosiglitazone (CAS 122320-73-4) Sales Forecast by Application (2021-2026)
5.2.2 Global Rosiglitazone (CAS 122320-73-4) Revenue Forecast by Application (2021-2026)
5.2.3 Global Rosiglitazone (CAS 122320-73-4) Price Forecast by Application (2021-2026)

3 North America Rosiglitazone (CAS 122320-73-4) Market Facts & Figures
3.2 North America Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
3.3 North America Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
3.4 North America Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)

4 Europe Rosiglitazone (CAS 122320-73-4) Market Facts & Figures
4.2 Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
4.3 Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
4.4 Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)

5 China Rosiglitazone (CAS 122320-73-4) Market Facts & Figures
5.2 China Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
5.3 China Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
5.4 China Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)

6 Japan Rosiglitazone (CAS 122320-73-4) Market Facts & Figures
6.2 Japan Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
6.3 Japan Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
6.4 Japan Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)

7 Southeast Asia Rosiglitazone (CAS 122320-73-4) Market Facts & Figures
7.2 Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)

8 India Rosiglitazone (CAS 122320-73-4) Market Facts & Figures
8.2 India Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
8.3 India Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
8.4 India Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Rosiglitazone (CAS 122320-73-4) Business
12.1 Hengrui Pharma
12.1.1 Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Corporation Information
12.1.2 Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Business Overview and Total Revenue
12.1.3 Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Products Offered
12.1.5 Hengrui Pharma Recent Development
12.2 GSK
12.2.1 GSK Rosiglitazone (CAS 122320-73-4) Corporation Information
12.2.2 GSK Rosiglitazone (CAS 122320-73-4) Business Overview and Total Revenue
12.2.3 GSK Rosiglitazone (CAS 122320-73-4) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Rosiglitazone (CAS 122320-73-4) Products Offered
12.2.5 GSK Recent Development
12.3 Taiji Group
12.3.1 Taiji Group Rosiglitazone (CAS 122320-73-4) Corporation Information
12.3.2 Taiji Group Rosiglitazone (CAS 122320-73-4) Business Overview and Total Revenue
12.3.3 Taiji Group Rosiglitazone (CAS 122320-73-4) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Taiji Group Rosiglitazone (CAS 122320-73-4) Products Offered
12.3.5 Taiji Group Recent Development
12.4 Shengjitang Pharma
12.4.1 Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Corporation Information
12.4.2 Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Business Overview and Total Revenue
12.4.3 Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Products Offered
12.4.5 Shengjitang Pharma Recent Development
12.5 Huanghe Pharma
12.5.1 Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Corporation Information
12.5.2 Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Business Overview and Total Revenue
12.5.3 Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Products Offered
12.5.5 Huanghe Pharma Recent Development
12.6 Wanma Pharma
12.6.1 Wanma Pharma Rosiglitazone (CAS 122320-73-4) Corporation Information
12.6.2 Wanma Pharma Rosiglitazone (CAS 122320-73-4) Business Overview and Total Revenue
12.6.3 Wanma Pharma Rosiglitazone (CAS 122320-73-4) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Wanma Pharma Rosiglitazone (CAS 122320-73-4) Products Offered
12.6.5 Wanma Pharma Recent Development
12.7 Jingxin Pharma
12.7.1 Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Corporation Information
12.7.2 Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Business Overview and Total Revenue
12.7.3 Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Products Offered
12.7.5 Jingxin Pharma Recent Development
12.8 STADA
12.8.1 STADA Rosiglitazone (CAS 122320-73-4) Corporation Information
12.8.2 STADA Rosiglitazone (CAS 122320-73-4) Business Overview and Total Revenue
12.8.3 STADA Rosiglitazone (CAS 122320-73-4) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 STADA Rosiglitazone (CAS 122320-73-4) Products Offered
12.8.5 STADA Recent Development

13 Rosiglitazone (CAS 122320-73-4) Manufacturing Cost Analysis
13.1 Rosiglitazone (CAS 122320-73-4) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Rosiglitazone (CAS 122320-73-4)
13.4 Rosiglitazone (CAS 122320-73-4) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Rosiglitazone (CAS 122320-73-4) Distributors List
14.3 Rosiglitazone (CAS 122320-73-4) Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Rosiglitazone (CAS 122320-73-4) Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Rosiglitazone (CAS 122320-73-4) Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Rosiglitazone (CAS 122320-73-4) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Rosiglitazone (CAS 122320-73-4) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Rosiglitazone (CAS 122320-73-4) Players to Combat Covid-19 Impact
Table 8. Global Market Rosiglitazone (CAS 122320-73-4) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Region (2015-2020)
Table 10. Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Region (2015-2020)
Table 11. Global Rosiglitazone (CAS 122320-73-4) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Region (2015-2020)
Table 13. Global Rosiglitazone (CAS 122320-73-4) Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Rosiglitazone (CAS 122320-73-4) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Rosiglitazone (CAS 122320-73-4) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Rosiglitazone (CAS 122320-73-4) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Rosiglitazone (CAS 122320-73-4) (Kg) of Key Companies (2015-2020)
Table 18. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Company (2015-2020)
Table 19. Global Rosiglitazone (CAS 122320-73-4) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Company (2015-2020)
Table 21. Global Rosiglitazone (CAS 122320-73-4) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rosiglitazone (CAS 122320-73-4) as of 2019)
Table 22. Global Rosiglitazone (CAS 122320-73-4) Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Rosiglitazone (CAS 122320-73-4) Manufacturing Sites and Area Served
Table 24. Manufacturers Rosiglitazone (CAS 122320-73-4) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Rosiglitazone (CAS 122320-73-4) Players
Table 27. Global Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Type (2015-2020)
Table 28. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Type (2015-2020)
Table 29. Global Rosiglitazone (CAS 122320-73-4) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Rosiglitazone (CAS 122320-73-4) Price (Kg) by Type (2015-2020)
Table 31. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Type (2021-2026)
Table 32. Global Rosiglitazone (CAS 122320-73-4) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Type (2021-2026)
Table 34. Global Rosiglitazone (CAS 122320-73-4) Price (Kg) by Type (2021-2026)
Table 35. Global Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Application (2015-2020)
Table 36. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Application (2015-2020)
Table 37. Global Rosiglitazone (CAS 122320-73-4) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Rosiglitazone (CAS 122320-73-4) Price (Kg) by Application (2015-2020)
Table 39. Global Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Application (2021-2026)
Table 40. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Application (2021-2026)
Table 41. Global Rosiglitazone (CAS 122320-73-4) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Application (2021-2026)
Table 43. Global Rosiglitazone (CAS 122320-73-4) Price (Kg) by Application (2021-2026)
Table 44. United States Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Company (2015-2020)
Table 45. United States Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
Table 46. United States Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Type (2015-2020)
Table 47. United States Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
Table 48. United States Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Application (2015-2020)
Table 49. United States Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)
Table 50. Europe Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Company (2015-2020)
Table 51. Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
Table 52. Europe Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Type (2015-2020)
Table 53. Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
Table 54. Europe Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Application (2015-2020)
Table 55. Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
Table 56. China Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Company (2015-2020)
Table 57. China Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
Table 58. China Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Type (2015-2020)
Table 59. China Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
Table 60. China Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Application (2015-2020)
Table 61. China Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)
Table 62. Japan Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Company (2015-2020)
Table 63. Japan Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
Table 64. Japan Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Type (2015-2020)
Table 65. Japan Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
Table 66. Japan Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Application (2015-2020)
Table 67. Japan Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)
Table 74. India Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Company (2015-2020)
Table 75. India Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company (2015-2020)
Table 76. India Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Type (2015-2020)
Table 77. India Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2015-2020)
Table 78. India Rosiglitazone (CAS 122320-73-4) Sales (Kg) by Application (2015-2020)
Table 79. India Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2015-2020)
Table 80. Hengrui Pharma Corporation Information
Table 81. Hengrui Pharma Description and Business Overview
Table 82. Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Product
Table 84. Hengrui Pharma Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. GSK Rosiglitazone (CAS 122320-73-4) Product
Table 89. GSK Recent Development
Table 90. Taiji Group Corporation Information
Table 91. Taiji Group Description and Business Overview
Table 92. Taiji Group Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Taiji Group Rosiglitazone (CAS 122320-73-4) Product
Table 94. Taiji Group Recent Development
Table 95. Shengjitang Pharma Corporation Information
Table 96. Shengjitang Pharma Description and Business Overview
Table 97. Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Product
Table 99. Shengjitang Pharma Recent Development
Table 100. Huanghe Pharma Corporation Information
Table 101. Huanghe Pharma Description and Business Overview
Table 102. Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Product
Table 104. Huanghe Pharma Recent Development
Table 105. Wanma Pharma Corporation Information
Table 106. Wanma Pharma Description and Business Overview
Table 107. Wanma Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Wanma Pharma Rosiglitazone (CAS 122320-73-4) Product
Table 109. Wanma Pharma Recent Development
Table 110. Jingxin Pharma Corporation Information
Table 111. Jingxin Pharma Description and Business Overview
Table 112. Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Product
Table 114. Jingxin Pharma Recent Development
Table . STADA Corporation Information
Table . STADA Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . STADA Description and Business Overview
Table . STADA Rosiglitazone (CAS 122320-73-4) Product
Table . STADA Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Rosiglitazone (CAS 122320-73-4) Distributors List
Table 123. Rosiglitazone (CAS 122320-73-4) Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Rosiglitazone (CAS 122320-73-4) Product Picture
Figure 2. Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Rosiglitazone (CAS 122320-73-4) Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Rosiglitazone (CAS 122320-73-4) Sales (Kg) Growth Rate (2015-2026)
Figure 10. Global Rosiglitazone (CAS 122320-73-4) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Rosiglitazone (CAS 122320-73-4) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Rosiglitazone (CAS 122320-73-4) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Rosiglitazone (CAS 122320-73-4) Sales (Kg) Growth Rate (2015-2026)
Figure 16. Europe Rosiglitazone (CAS 122320-73-4) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Rosiglitazone (CAS 122320-73-4) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Rosiglitazone (CAS 122320-73-4) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Rosiglitazone (CAS 122320-73-4) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Rosiglitazone (CAS 122320-73-4) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Rosiglitazone (CAS 122320-73-4) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Rosiglitazone (CAS 122320-73-4) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Rosiglitazone (CAS 122320-73-4) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Rosiglitazone (CAS 122320-73-4) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Rosiglitazone (CAS 122320-73-4) Players Market Share by Revenue in Rosiglitazone (CAS 122320-73-4) 2015 & 2019
Figure 27. Rosiglitazone (CAS 122320-73-4) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Type (2015-2020)
Figure 29. Global Rosiglitazone (CAS 122320-73-4) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Application (2015-2020)
Figure 31. Global Rosiglitazone (CAS 122320-73-4) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type in 2019
Figure 33. United States Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type in 2019
Figure 34. Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company in 2019
Figure 35. Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type in 2019
Figure 36. Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application in 2019
Figure 37. China Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company in 2019
Figure 38. China Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type in 2019
Figure 39. China Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application in 2019
Figure 40. Japan Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company in 2019
Figure 41. Japan Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type in 2019
Figure 42. Japan Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application in 2019
Figure 46. India Rosiglitazone (CAS 122320-73-4) Sales Market Share by Company in 2019
Figure 47. India Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type in 2019
Figure 48. India Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application in 2019
Figure 49. Hengrui Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Taiji Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Shengjitang Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Huanghe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Wanma Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Jingxin Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. STADA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Rosiglitazone (CAS 122320-73-4)
Figure 59. Manufacturing Process Analysis of Rosiglitazone (CAS 122320-73-4)
Figure 60. Rosiglitazone (CAS 122320-73-4) Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---